Champions Oncology, Inc. announced that its Chief Financial Officer and Executive Vice President, Gary G. Gemignani, informed the company of his intention to resign. Mr. Gemignani informed the company that his resignation was not related to any disagreement with the company. Mr. Gemignani has agreed to remain as the company's Chief Financial Officer for a transition period while the company searches for a new Chief Financial Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.715 USD | -0.95% | +1.62% | -16.10% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
1st Jan change | Capi. | |
---|---|---|
-16.10% | 64.71M | |
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |
- Stock Market
- Equities
- CSBR Stock
- News Champions Oncology, Inc.
- Champions Oncology, Inc. Announces Resignation of Gary G. Gemignani as Chief Financial Officer and Executive Vice President